Upload
Featured Recent Articles Topics Upload Login Sign Up

Search Results for 'cll ibrutinib'

cll ibrutinib published presentations and documents on DocSlides.

Ibrutinib : First-in Class Inhibitor of BTK
Ibrutinib : First-in Class Inhibitor of BTK
by briana-ranney
Forms a specific and irreversible bond with cyste...
Mechanisms of
Mechanisms of
by giovanna-bartolotta
Ibrutinib. Sensitivity and Resistance in CLL. Y....
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
by ellena-manuel
Pharmacist Focus on BTK Inhibitors Moderator Shil...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
CLL: clinical cases Celso Arrais
CLL: clinical cases Celso Arrais
by genevieve
Conflict of Interests. I declare NO relevant confl...
CLL Stromal cell protect
CLL Stromal cell protect
by tawny-fly
CLL Stromal cell protect Conventional therapies V...
Btk inhibition in Mantle cell Lymphoma & CLL
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
2022 Spring Oncology Conference
2022 Spring Oncology Conference
by byrne
Evolving Treatment Strategies. for CLL/SLL and MCL...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
Research To Practice ASH 2022 CLL Updates
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...